A Novel Therapeutic Target For Human Triple-negative Breast Cancer!
Scientists found that MAPK4 is overexpressed in many patients with triple-negative breast cancer by analyzing public genomic databases. They also found that silencing MAPK4 inhibited the growth of human triple-negative...